|
Administered insulin (IU/day)
|
19.1 (13.1)
|
23.7 (40.1)*a
|
20.3 (30.1)
|
<0.05*
|
|
Plasma glucose level (mg/dL)
|
138.6 (39.1)
|
146.1 (49.9)*a
|
143.9 (45.9)
|
<0.01*
|
|
Capillary glucose level (mg/dL)
|
146.1 (45.8)
|
155.3 (63.6)*a
|
150.1 (41.9)*b,c
|
<0.001*a
|
|
<0.01*b,c
|
|
Mean capillary glycemia on ICU day 1 (mg/dL)
|
147.5 (40.2)
|
160 (55.5)*d
|
145.6 (46.6)
|
<0.01*
|
|
Peak glucose level (mg/dL)
|
181.3 (52)
|
193.6 (74.6)
|
191.3 (65.8)
|
0.68
|
|
Number of capillary glycemia measurements
|
3605
|
3523
|
3557
|
0.57
|
|
Number of measurements per patient/day
|
5.7 (3.4)
|
5.81 (3.2)
|
5.46 (2.9)
|
0.56
|
|
Percentage of controls on 80–150 mg/dL
|
59 %
|
57.6 %
|
59.59 %
|
0.82
|
|
Hypoglycemia (50–80 mg/dL)
|
53 (1.48 %)
|
127 (3.63 %)*d
|
44 (1.25 %)
|
<0.05*
|
|
Hypoglycemia (<50 mg/dL)
|
-
|
4 (0.11 %)
|
1 (0.02 %)
|
0.32
|
|
Capillary glucose SD
|
45.83
|
63.67*d
|
41.98
|
<0.01*
|
|
Glycemic lability index (ICU days 1–28)
|
0.58 (0.2–1.4)
|
0.71 (0.3–1.9)*d
|
0.44 (0.2–1.2)
|
<0.05*
|
|
Glycemic lability index (ICU days 1–7)
|
0.27 (0.1–0.7)
|
0.6 (0.2–1.2)*d
|
0.27 (0.2–0.8)
|
<0.05*
|
|
Glycemic variability SD (mg/dL) (ICU days 1–28)
|
33.6 (18.4)
|
49.1 (21.5)*a
|
41.1 (9.3)
|
<0.01*
|
|
Glycemic variability SD (mg/dL) (ICU days 1–7)
|
43.2 (4.9)
|
68.5 (13.5)*d
|
42.5 (2.7)
|
<0.01*
|
|
Glycemic CV (%) (ICU days 1–28)
|
27.9 (5.8)
|
32.4 (11.2)
|
27.8 (5.2)
|
0.13
|
|
Glycemic CV (%) (ICU days 1–7)
|
28.3 (1.9)
|
42.6 (8.2)*d
|
28.4 (2.1)
|
<0.001*
|
